Inventor · disambiguated record
David Ayares
Also filed as: AYARES DAVID · AYARES DAVID L · AYARES DAVID LEE
12 granted patents·17 pending applications·135 citations·filing 1999–2021
91Inventor score
Top patents by PatentIndex Score
29 records- 0192US8106251B2Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferaseAYARES DAVID·Filed 2005·Granted Jan 31, 2012·39 cites·7 claims
- 0291US7795493B2Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2003·Granted Sep 14, 2010·34 cites·8 claims
- 0389US9339519B2Multi-transgenic pigs for diabetes treatmentAYARES DAVID·Filed 2010·Granted May 17, 2016·19 cites·28 claims
- 0487US10149461B2Immunocompromised ungulatesREVIVICOR INC·Filed 2015·Granted Dec 11, 2018·9 cites·16 claims
- 0587US10130737B2Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2014·Granted Nov 20, 2018·10 cites·21 claims
- 0685US9585374B2Ungulates with genetically modified immune systemsWELLS KEVIN·Filed 2009·Granted Mar 7, 2017·10 cites·20 claims
- 0784US10300112B2Transgenic ungulates expressing CTLA4-IG and uses thereofAYARES DAVID LEE·Filed 2012·Granted May 28, 2019·10 cites·11 claims
- 0877US11172658B2Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2018·Granted Nov 16, 2021·1 cites·4 claims
- 0971US11085054B2Ungulates with genetically modified immune systemsREVIVICOR INC·Filed 2019·Granted Aug 10, 2021·0 cites·15 claims
- 1071US10383317B2Multi-transgenic pigs for diabetes treatmentREVIVICOR INC·Filed 2016·Granted Aug 20, 2019·1 cites·31 claims
- 1169US11179496B2Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereofAYARES DAVID·Filed 2013·Granted Nov 23, 2021·2 cites·21 claims
- 1261US2008026457A1Ungulates with genetically modified immune systemsWELLS KEVIN·Filed 2007·Application pending·0 cites
- 1361US2017183685A1Ungulates with Genetically Modified Immune SystemsREVIVICOR INC·Filed 2017·Application pending·0 cites
- 1458US10912863B2Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferaseREVIVICOR INC·Filed 2018·Granted Feb 9, 2021·0 cites·12 claims
- 1558US2015106959A1Porcine Animals Lacking Any Expression of Functional Alpha 1,3 GalactosyltransferasePHELPS CAROL J·Filed 2014·Application pending·0 cites
- 1652US2022211018A1Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantationREVIVICOR INC·Filed 2021·Application pending·0 cites
- 1752US2012282226A1Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 GalactosyltransferaseAYARES DAVID·Filed 2011·Application pending·0 cites
- 1850US2012255047A1Porcine Animals Lacking Any Expression of Functional Alpha 1,3 GalactosyltransferasePHELPS CAROL J·Filed 2010·Application pending·0 cites
- 1949US2006130157A1Ungulates with genetically modified immune systemsWELLS KEVIN·Filed 2005·Application pending·0 cites
- 2049US2009186097A1Transgenic Ungulates Expressing CTLA4-IG and Uses ThereofAYARES DAVID LEE·Filed 2006·Application pending·0 cites
- 2148US2022257829A1Compositions and methods for preventing allergiesREVIVICOR INC·Filed 2019·Application pending·0 cites
- 2245US2003024002A1Method of preparing a somatic cell for nuclear transferFiled 2002·Application pending·0 cites
- 2341US2004208846A1Mini-Ad vector for immunizationFiled 2004·Application pending·0 cites
- 2440US2001046965A1Adenovirus E1-complementing cell linesFiled 2001·Application pending·0 cites
- 2539US2008250517A1MethodsCOLMAN ALAN·Filed 2006·Application pending·0 cites
- 2639US2012090039A1Immunocompromised UngulatesAYARES DAVID L·Filed 2011·Application pending·0 cites
- 2736US2003192066A1Minimal adenoviral vectorGENSTAR THERAPEUTICS CORP·Filed 2002·Application pending·0 cites
- 2836US2018249688A1Multi-Transgenic Pig for XenotransplantationREVIVICOR INC·Filed 2016·Application pending·0 cites
- 2927US2002012660A1Method of preparing a somatic cells for nuclear transferFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Ayares files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →